4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000029
CEO bought 255,000 shares at an average $0.01 ($2,859)
From the SEC's structured data for this filing
Trades in this filing
Collier Alan Brian · CEO
Table I: Non-derivative
21 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-05-02 | Purchase : show line 1 in the form | +33,737 | $0.01 | $371 | 21,370,860 | D |
| 2019-05-02 | Purchase : show line 2 in the form | +66,263 | $0.01 | $762 | 21,437,123 | D |
| 2019-05-02 | Purchase : show line 3 in the form | +5,000 | $0.01 | $57 | 21,442,123 | D |
| 2019-05-02 | Purchase : show line 4 in the form | +3,200 | $0.01 | $35 | 21,445,323 | D |
| 2019-05-02 | Purchase : show line 5 in the form | +24,800 | $0.01 | $273 | 21,470,123 | D |
| 2019-05-02 | Purchase : show line 6 in the form | +10,000 | $0.01 | $109 | 21,480,123 | D |
| 2019-05-02 | Purchase : show line 7 in the form | +18,000 | $0.01 | $198 | 21,498,123 | D |
| 2019-05-02 | Purchase : show line 8 in the form | +2,000 | $0.01 | $22 | 21,500,123 | D |
| Open-market purchases · 255,000 sh · avg $0.01 · $2,859 | ||||||
Loading xslF345X03/primary_doc.xml…